1. Home
  2. MHK vs GKOS Comparison

MHK vs GKOS Comparison

Compare MHK & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mohawk Industries Inc.

MHK

Mohawk Industries Inc.

HOLD

Current Price

$112.60

Market Cap

6.2B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$129.80

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHK
GKOS
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
MHK
GKOS
Price
$112.60
$129.80
Analyst Decision
Buy
Strong Buy
Analyst Count
11
12
Target Price
$126.10
$126.92
AVG Volume (30 Days)
592.3K
1.3M
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.90
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$3.38
$23.32
Revenue Next Year
$3.09
$27.43
P/E Ratio
$56.62
N/A
Revenue Growth
N/A
32.33
52 Week Low
$92.99
$73.16
52 Week High
$143.13
$148.11

Technical Indicators

Market Signals
Indicator
MHK
GKOS
Relative Strength Index (RSI) 60.41 55.91
Support Level $104.49 $96.44
Resistance Level $115.00 $130.23
Average True Range (ATR) 4.11 6.30
MACD 0.76 1.36
Stochastic Oscillator 79.54 92.55

Price Performance

Historical Comparison
MHK
GKOS

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: